Enhanc3D Genomics raised €11M in a Series A round in Oct 2022. The company is based in Cambridge, UK. Investors in the round: BGF, Bioqube Ventures, Parkwalk Advisors. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
